Optimized fluorescent probe combinations for evaluation of proliferation and necrosis in anthracycline-treated leukaemic cell lines

Cell Proliferation

Volumn 32, Issue 4, 1999, Pages 203-213

  Boutonnat, J ^a,c   Barbier, M ^a   Muirhead, K ^b   Mousseau, M ^c   Ronot, X ^a   Seigneurin, D ^a  

^a INSTITUT ALBERT BONNIOT   (France)

^b SciGro   (United States)

^c HÔPITAL MICHALLON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ANTHRACYCLINE; DAUNORUBICIN; DOXORUBICIN; FLUORESCENT DYE; PENICILLIN G; PROPIDIUM IODIDE; STREPTOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE;

EID: 0033454069     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2184.1999.3240203.x     Document Type: Article

References (16)

1. BOUTONNAT J, MUIRHEAD KM, BARBIER M, MOUSSEAU M, RONOT X, SEIGNEURIN D. (1998) PKH26 probe in the study of the proliferation of chemoresistant leukemic sublines. Anticancer Res. 18, 4243.
2. DARZYNKIEWICZ Z, JUAN G, LI X, GORCZYCA W, MURAKAMI T, TRAGANOS F. (1997) Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 27, 1.
3. DOLBEARE F. (1996) Bromodeoxyuridine: a diagnostic tool in biology and medecine, Part III. Proliferation in normal, injured and diseared tissue, growth factors, differentiation, DNA replication sites and in situ hybridation. Histochem. J. 28, 531.
4. FOON KA, GALE RP. (1992) Therapy of acute myelogenous leukemia. Blood Rev. 6, 15.
5. FREZARD F, GARNIER-SUILLEROT A. (1991) DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives. Biochemistry 30, 5038.
6. HAUGLAND RP, WHITAKER JE, MOORE PL, REESE M. (1991) Cascade blue derivatives: water soluble, reactive, blue emission dyes evaluated as fluorescent labels and tracers. Anal. Biochem. 198, 119.
7. HORAN P, MELNICOFF M, JENSEN B, SLEZAK S. (1990) Fluorescent cell labelling for in vivo and in vitro cell tracking. Meth Cell Biol. 33, 469.
8. KRISHAN A, GANAPATHI R (1980) Laser flow cytometric studies on the intracellular fluorescence of anthracyclines. Cancer Res. 40, 3895.
9. LACOMBE F, BELLOC F, DUMAIN P et al. (1994) Detection of Cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry. Blood 84, 716.
10. LIST AF. (1996) Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10, 937.
11. LOE DW, DEELEY RG, COLE SPC. (1996) Biology of the multidrug resistance-associated protein, MRP. Eur. J. Cancer, 32A 945.
12. LOWY RJ. (1995) Evaluation of triple-band filters for quantitative epifluorescence microscopy. J. Microscopy 178, 240.
13. LOZZIO CB, LOZZIO BB. (1975) Human chronic myelogenousleukemia cell line with positive philadelphia chromosome. Blood 45, 321.
14. 1H-NMR study. J. Biol. Chem. 271, 27608.
15. VAN ACKER LK, VAN HOVE LM, BOOGAERTS MA. (1993) Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using Daunorubicin and monoclonal antibodies. Cytometry 14, 736.
16. YAMAMURA Y, RODRIGUEZ N, SCHWARTZ A et al. (1995) A new flow cytometric method for quantitative assessment of lymphocyte mitogenic potentials. Cell. Mol. Biol. 41, S121.